Newsroom

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce aujourd’hui que le Tribunal des activités économiques de Paris a fait droit à sa demande d’ouverture de procédure de sauvegarde afin de restructurer son endettement dans un cadre juridique protecteur. Dans ce cadre, le passif de la...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, announces today that the Paris Commercial Court granted its request to initiate a safeguard procedure to restructure its debt within a protective legal framework. As such, the Company’s liabilities incurred prior to the decision are frozen until the end of...

IRVINE, Calif.--(BUSINESS WIRE)--Ingram Micro Holding Corporation (the “Company”) today announced that Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC (the “Selling Stockholder”), has commenced a secondary offering of $330 million of its common stock (“Common Stock,” and such offering, the “Offering”), pursuant to an automatic shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). In addition, the Selling Stockholder expects to grant the underwriter...

MIAMI--(BUSINESS WIRE)--The Hackett Group, Inc. (NASDAQ: HCKT), a leading Gen AI strategic consulting and digital transformation firm that enables Digital World Class® performance, today announced its financial results for the first quarter, which ended on March 27, 2026. "Over the past two years, we have made disciplined, systematic investments to build a cohesive and highly differentiated AI foundation," stated Ted A. Fernandez, Chairman and CEO of The Hackett Group, Inc. "We believe that the...

NEW YORK--(BUSINESS WIRE)--Sixth Street Specialty Lending, Inc. (NYSE: TSLX, or the “Company”) today reported financial results for the first quarter ended March 31, 2026. Please view a printable version of the 2026 First Quarter Results. Conference Call Information: A conference call to discuss the Company’s financial results will be held at 8:30 a.m. Eastern Time on May 6, 2026. The conference call will be broadcast live in listen-only mode on the Investor Resources section of TSLX’s website...

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech Announces Q4 and Full Fiscal Year 2026 Results...

IRVINE, Calif.--(BUSINESS WIRE)--loanDepot announces first quarter 2026 financial results...

DALLAS--(BUSINESS WIRE)--Resources Connection, Inc. (“RGP” or the “Company”) (Nasdaq: RGP), a global professional services firm, today announced planned changes to its Board of Directors and governance structure in connection with its 2026 Annual Meeting of Stockholders. A. Robert Pisano, Chair of the Board, has informed the Board of his intention to retire and resign from his roles as a director and as Chair, effective as of the Company’s 2026 Annual Meeting of Stockholders, one year prior to...

SAN FRANCISCO--(BUSINESS WIRE)--Visa (NYSE: V) today announced its participation in the following investor conferences. On Tuesday, May 19, Chris Suh, Chief Financial Officer, will present at the J.P. Morgan Global Technology, Media and Communications Conference. The discussion will begin at 9:25 a.m. Eastern Time and last for approximately 35 minutes. On Thursday, May 28, Ryan McInerney, Chief Executive Officer, will present at the Bernstein Strategic Decisions Conference. The discussion will...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2026, provided an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and pipeline development milestones. “Exelixis made significant progress in the first quarter of 2026 as we remain focused on our goal of building next-generation oncology franchises,” said Michael M. Morrissey, Ph.D., President and Chief Executive Officer, E...